Kamada Ltd (NASDAQ:KMDA)
| 4.85 BATS BZX Real-Time Price As of 1:23pm ET |  +0.14 / +2.97%Today’s Change | 3.72 Today|||52-Week Range 5.72 | +20.95% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $214.3M |
Company Description
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, which are manufactured by third parties. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.
Contact Information
Kamada Ltd. Science Park Rehovot Hamerkaz 7670402 |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Amir London | Chief Executive Officer |
| Eran Nir | Chief Operating Officer |
| Chaime Orlev | Chief Financial Officer |
| Naveh Tov | VP-Clinical Development & Medical Director |
| Nir Livneh | Secretary, Vice President & General Counsel |
